The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]
  • There was no gene found in the curated document received from the VCI/VCEP
  • Despite there being a valid 'cspec' property in the messages there's a discrepancy in message contents and CSPEC data: * Message Gene: undefined CSPEC Genes: [] * Message MONDOs: MONDO:0044970 CSPEC MONDO: []
  • No CSPEC computed assertion could be determined for this classification!


Variant: NC_012920.1(MT-TS1):m.7445A>T

CA414792846

631469 (ClinVar)

Gene: N/A
Condition: mitochondrial disease
Inheritance Mode: Mitochondrial inheritance
UUID: cbbd381c-36c9-46a4-91be-03c07cf8affa
Approved on: 2024-07-08
Published on: 2024-12-09

HGVS expressions

NC_012920.1:m.7445A>T
J01415.2:m.7445A>T
ENST00000361624.2:c.1542A>T

Uncertain Significance

Met criteria codes 1
PM5_Supporting
Not Met criteria codes 3
PS4 PP3 PM2

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specification: ClinGen Mitochondrial Disease Nuclear and Mitochondrial Expert Panel Specifications to the ACMG/AMP Variant Interpretation Guidelines Version 1_mtDNA

Criteria Specification Approval History
Criteria Specifications for this VCEP
Evidence submitted by expert panel
Mitochondrial Diseases VCEP
The m.7445A>T (p.*514S) variant in MT-CO1 has been reported in one individual with primary mitochondrial disease to date (PMID: 18639500). This person was Chinese and had severe hearing loss onset at age one year. There was no known precipitating event. The variant was homoplasmic in blood. There was no family history of hearing loss. This variant is present in population databases (Mitomap's 51,863 sequences: AF=0.049%; Helix's 196,554 sequences: AF=0.002%; gnomAD v3.1.2: absent). There are no in-silico prediction tools for a stop-loss variant in mitochondrial DNA, although this variant would not be expected to cause run-through due to the excision of the tRNA immediately adjacent. Another variant at this position has been classified as pathogenic – m.7445A>G (PM5_supporting). In summary, this variant meets criteria to be classified as uncertain significance for primary mitochondrial disease inherited in a mitochondrial manner. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Variant Curation Expert Panel on July 8, 2024. Mitochondrial DNA-specific ACMG/AMP criteria applied (PMID: 32906214): PM5_supporting.
Met criteria codes
PM5_Supporting
Another variant at this position has been classified as pathogenic – m.7445A>G (PM5_supporting).
Not Met criteria codes
PS4
The m.7445A>T (p.*514S) variant in MT-CO1 has been reported in one individual with primary mitochondrial disease to date (PMID: 18639500). This person was Chinese and had severe hearing loss onset at age one year. There was no known precipitating event. The variant was homoplasmic in blood. There was no family history of hearing loss.
PP3
There are no in-silico prediction tools for a stop-loss variant in mitochondrial DNA, although this variant would not be expected to cause run-through due to the excision of the tRNA immediately adjacent.
PM2
This variant is present in population databases (Mitomap's 51,863 sequences: AF=0.049%; Helix's 196,554 sequences: AF=0.002%; gnomAD v3.1.2: absent).
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
¤ Powered by BCM's Genboree.